First case report of bacteremia due to 'Campylobacter-like organism-3'

We report a case of bacteremia caused by a rare Helicobacter species, Campylobacter-like organism-3 (CLO-3), in a 75-year-old man with prostate cancer and indwelling urethral catheter for urinary retention.

Oral levofloxacin (500mg per day) was effective, although the results of antimicrobial susceptibility testing were unknown. Non-film-like, small, clear colonies were isolated on blood agar after 72h of microaerobic incubation at 37°C. Biochemical testing indicated that the isolates were catalase-positive, negative for nitrate reduction and urease activity, and positive for indoxyl acetate hydrolysis. The isolate was identified as CLO-3 by sequence analysis of the 16S rRNA and hsp60 genes. Although CLO-3 is known to cause enterocolitis, bacteremia due to CLO-3 has not been described. There have been an increasing number of reports of bacteremia caused by Helicobacter cinaedi and Helicobacter fennelliae which firstly reported as CLO-1 and CLO-2, and CLO-3 may represent another an emerging cause of Helicobacter-induced bacteremia.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2015 Nov 27 [Epub ahead of print]

Itaru Nakamura, Kiyofumi Ohkusu, Yoshihiro Nakagami, Masaaki Tachibana, Tetsuya Matsumoto

Department of Infection Prevention and Control, Tokyo Medical University Hospital, Tokyo, Japan. , Department of Microbiology, Tokyo Medical University, Tokyo, Japan. Department of Urology, Tokyo Medical University Hospital, Tokyo, Japan. , Department of Urology, Tokyo Medical University Hospital, Tokyo, Japan. , Department of Microbiology, Tokyo Medical University, Tokyo, Japan.

PubMed

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe